March 7, 2022
Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for Skin Cancer Drug
Evaxion Biotech has now finalized recruitment for Phase 1/2a clinical trial of EVX-02 in adjuvant melanoma patients.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Evaxion Biotech